Uploaded May 2024 | Updated September 2026, 2 weeks ago
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:22 Which prostate cancer patients are most eligible for triple therapy?
2:08 Which Gleason scores are most likely to require triple therapy?
3:31 Is triple therapy always required in certain situations? What about lymph nodes?
7:21 Is triple therapy more advisable for very young prostate cancer patients?
9:01 What are the usual side effects associated with hormone therapy?
11:32 In what sequence are these treatments given?
12:55 How long does a course of hormone therapy usually last?
13:43 Can improving imagine techniques lessen the impact of hormone therapies?
15:04 How does chemotherapy for prostate cancer compare with other cancers?
17:51 Can chemotherapy, hormone therapy, and radiation all be tried again after recurrence?
19:11 Does the radiation treatment used in triple therapy need to be done at a center of excellence?
20:50 Alex's conclusions
23:23 If you need more help
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:22 Which prostate cancer patients are most eligible for triple therapy?
2:08 Which Gleason scores are most likely to require triple therapy?
3:31 Is triple therapy always required in certain situations? What about lymph nodes?
7:21 Is triple therapy more advisable for very young prostate cancer patients?
9:01 What are the usual side effects associated with hormone therapy?
11:32 In what sequence are these treatments given?
12:55 How long does a course of hormone therapy usually last?
13:43 Can improving imagine techniques lessen the impact of hormone therapies?
15:04 How does chemotherapy for prostate cancer compare with other cancers?
17:51 Can chemotherapy, hormone therapy, and radiation all be tried again after recurrence?
19:11 Does the radiation treatment used in triple therapy need to be done at a center of excellence?
20:50 Alex's conclusions
23:23 If you need more help
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
